Activation Barriers to Structural Transition Determine Deposition Rates of Alzheimer's Disease Aβ Amyloid
- 1 June 2000
- journal article
- Published by Elsevier in Journal of Structural Biology
- Vol. 130 (2-3) , 174-183
- https://doi.org/10.1006/jsbi.2000.4276
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinPublished by Elsevier ,2004
- Alzheimer's Disease Amyloid Propagation by a Template-Dependent Dock-Lock MechanismBiochemistry, 2000
- Stereochemical specificity of Alzheimer's disease ?-peptide assemblyBiopolymers, 1999
- Propagating structure of Alzheimer’s β-amyloid (10–35) is parallel β-sheet with residues in exact registerProceedings of the National Academy of Sciences, 1998
- PATHOLOGIC CONFORMATIONS OF PRION PROTEINSAnnual Review of Biochemistry, 1998
- Aβ deposition inhibitor screen using synthetic amyloidNature Biotechnology, 1997
- Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic AspectsBrain Pathology, 1996
- Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque CompetenceBiochemistry, 1996
- In VitroGrowth of Alzheimer's Disease β-Amyloid Plaques Displays First-Order Kinetics†Biochemistry, 1996
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's DiseaseNeurology, 1995